infl ammatory response syndrome (SIRS). 5, 6 Th is initial stage of ARDS is known as early acute lung injury and may exist even before the patient is intubated. However, subsequent mechanical ventilation (MV) with inappropriate ventilator settings can cause a secondary ventilatorinduced lung injury (VILI) that, when combined with SIRS, acts to advance lung injury toward ARDS ( Fig 1 ) . 5 Th e fact that lung injury develops slowly potentially gives caregivers time to block progression of acute lung injury (ALI) in its early stages, thus reducing the chances of it developing into full-blown ARDS. Nevertheless, current treatments for ARDS, which have proven largely disappointing, are supportive in nature and are applied only once lung injury has become well established. [7] [8] [9] [10] Preventing ARDS from developing would, thus, represent a paradigm shift in the way that medicine is practiced. Accordingly, in this article, we focus on the evidence suggesting that the incidence of ARDS can be signifi cantly reduced if appropriately set protective MV is administered to at-risk patients well before any overt clinical signs of ALI are present.
Current Treatments for Established ARDS
To date, all attempts at pharmacologic prevention of ARDS have been ineff ective, 11 so supportive treatment of the established syndrome has been seen as the only clinical option. 3, 4 Unfortunately, success at treating established ARDS has been generally dismal. 3, 4, [7] [8] [9] [10] Indeed, the only therapeutic strategies that have been shown to signifi cantly reduce mortality are low tidal volume (LV t ) MV, 12 prone positioning, 13 and neuromuscular blockade. 14 Even so, the mortality from ARDS remains unacceptably high at . 40%. 15 To make matters worse, patients who survive ARDS oft en develop chronic lung 16 and neurologic dysfunction. 17 Although MV is a lifesaving therapy, 12 when applied inappropriately it will increase the incidence and mortality of ARDS by causing a secondary pathology known as VILI ( Fig 1 ) . 18 Th e infl ammatory mediators produced by VILI can then injure distant organs, leading to the development of multiorgan dysfunction syndrome that is frequently the ultimate cause of death in patients with ARDS. 19 Since treatment of established ARDS is very diffi cult, and the only strategy demonstrated to reduce ARDS mortality involves protective MV, the question arises: Would it be possible to use the ventilator as a therapeutic device in at-risk patients to prevent ARDS in the same preemptive manner in which drugs are used to prevent other diseases?
Clinical Studies Demonstrating ARDS Incidence Can Be Reduced

Patients in the ICU
Clinical meta-analyses have shown that early application of protective ventilation in both high-risk patients Figure 1 in the ICU and surgical patients can reduce the incidence of ARDS. [20] [21] [22] [23] [24] Multiple studies in patients in the ICU have shown that preemptive protective MV can reduce ARDS incidence. Th is has been shown with conventional MV (CMV) using a combination of LV t , positive endexpiratory pressure (PEEP), and recruitment maneuvers (RMs), 22 including a preemptive randomized clinical trial demonstrating that ARDS incidence can be reduced in high-risk patients in the ICU. 25 ARDS occurrence in trauma patients has also been lessened with early application of airway pressure release ventilation (APRV). 24 
Patients Undergoing Major Surgery
Reduced ARDS incidence has also been demonstrated in a group of patients with normal lungs who underwent extensive abdominal surgery and, thus, were at high risk for developing ARDS. Th e group ventilated with high tidal volume (V t) (12 mL/kg) plus zero PEEP developed signifi cantly more complications, including pneumonia, sepsis, septic shock, acute respiratory failure, and death, than did the group ventilated with LV t (6 mL/kg) plus 6 to 8 cm H 2 O PEEP combined with RMs. 26, 27 Th ese studies demonstrate clinical proof of concept that either early CMV using a combination of LV t , PEEP, and RMs or early APRV can reduce ARDS incidence. Nevertheless, the optimally protective mechanical breath for reducing ARDS incidence remains unknown. Indeed, LV t with low PEEP has been shown to actually increase mortality in surgical patients at high risk for ARDS. 28, 29 Minimizing a Ventilation Injury Cost Function MV can be delivered in a near limitless variety of confi gurations according to the value of the various parameters that defi ne its characteristics. Th e parameters most commonly manipulated in patients with ARDS include V t (the current goal being 6 mL/kg ideal body weight), plateau pressure (the desired maximum being typically 30 cm H 2 O), and PEEP (the goal being to reduce derecruitment at the end of expiration). 12 It seems natural to postulate that there must exist an optimal combination of mechanical breath parameters (ie, airway pressures, volumes, fl ows, rates, and their respective durations throughout each breath), which we have termed the mechanical breath profi le (MBP), 30 that would minimize progressive lung injury. We hypothesize that the optimal mechanical breath can be defi ned with respect to some function of the MBP parameters that quantifi es the injury potential of a given breath. One simple possibility for such a function is the pressure-time integral (PTI) 31 defi ned as:
where T tot is the duration of the entire breath during inspiration and expiration. 31 Th e PTI provides a general 
lm (surfactant sloughed into the alveolar lumen) and increase alveolar fl ooding (tan). Alveolar edema: Over time, nonprotective ventilation plus increased capillary permeability will completely destroy the surfactant fi lm resulting in total alveolar fl ooding (tan). RACE: At a certain level of surfactant disruption, alveoli become unstable, collapsing during expiration and reexpanding during inspiration. RACE signifi cantly exacerbates lung damage by contributing to surfactant deactivation and to dynamic microstrain-induced increases in permeability (small black arrows) signifi cantly exacerbating edema formation (solid red arrow). In addition, high alveolar surface tension secondary to surfactant deactivation alone causes edema and combined with increased permeability would greatly accelerate alveolar fl ooding (dotted red arrow). Once a portion of lung develops these key pathologic changes they establish a positive feedback loop exacerbating and accelerating progressive lung damage and if this sequence is unbroken will drive the lung into ARDS. RACE 5 repetitive alveolar collapse and expansion.
measure of both the degree of stress applied to the lungs and the duration over which the stress is applied during each breath. Even though PTI does not take into account the variable alveolar surface area being exposed to the ventilator pressure, it adds the important component of the duration over which the pressure is applied during a breath.
Our group has shown that the incidence of ARDS in both animals and patients is signifi cantly reduced with the APRV mode of ventilation by extending the duration of the end-inspiratory plateau and by minimizing the duration of the pressure release, which greatly increases the PTI. 24, [31] [32] [33] [34] In other words, protection against the development of ALI is conferred by much more than simply the values of V t , plateau pressure, and PEEP that are used; the durations over which these parameters are applied also determine whether lung injury will progress. Mode acronyms such as APRV or CMV, thus, do not encompass all the features of a mechanical breath that determine its injurious or protective impact because the temporal details of the mechanical breath can be critical to this impact. As a means of understanding the details of the MBP on the development of VILI, we have recently developed a computational model of a lung that is mechanically ventilated that simulates the tissue stresses and strains generated by various modes of MV. 35 By fi tting this model to dynamic airway pressure and lung volume data measured in rats we demonstrated that the MBP associated with appropriately set APRV is superior to protective CMV at recruiting the lung, maintaining homogeneous ventilation, and preventing repetitive alveolar collapse and expansion (RACE) during exhalation. 35 
Th e Optimally Protective Breath
Mechanisms of VILI
Th ere are several plausible mechanisms that could underlie the protective benefi ts of APRV relative to the pathogenesis of ARDS ( Fig 2 ) . In secondary ARDS, trauma, hemorrhagic shock, or sepsis can incite SIRS and cause an increase in capillary permeability that ultimately results in surfactant deactivation that, together with alveolar fl ooding, alters alveolar mechanics and, in particular, can lead to RACE. Lung tissue injury caused by RACE can be exacerbated by the development of 44 ) stress concentrations between air-fi lled alveoli and alveoli that are either collapsed 36 or edema fi lled. 37 Th us, heterogeneous ventilation, which creates stress concentrators, can also cause excessive strain on alveolar walls and combined with RACE drive progressive lung injury. 30, 38 
LV T , PEEP, and RMs
Th e factors that constitute an optimally protective breath for reducing ARDS incidence are currently unknown. Nevertheless, it is safe to assume that these factors include both reducing stress concentrations by maximizing the homogeneity of ventilation and minimizing RACE. Indeed, clinical studies have shown that early application of LV t ventilation with various levels of PEEP signifi cantly reduces the incidence of ARDS, presumably by reducing tissue overdistension in areas of stress concentration and by preventing RACE. 20, 24, 26, 39, 40 However, a recent study demonstrated that LV t alone applied to the normal lung during surgery in patients at high risk for developing ARDS was associated with increased mortality 28 and that LV t with high but not low PEEP increased postoperative pulmonary complications. 29 In contrast, Futier et al 26 showed that the combination of LV t , PEEP, and RMs signifi cantly reduced acute respiratory failure and mortality in patients undergoing major surgery. Th ese studies suggest that the optimally protective CMV breath will involve some appropriate combination of V t , PEEP, and RMs. 28, 29 
Airway Pressure Release Ventilation
Currently, APRV is thought of as a "rescue mode" to be used only in patients with ARDS who are refractory to any other ventilator strategy. [41] [42] [43] Th eoretically, APRV should minimize the primary physiologic mechanisms of VILI by maintaining an "open lung, " resulting in homogeneous lung ventilation. In addition, APRV gradually infl ates or "nudges" the lung open, which minimizes the tissue damage associated with aggressive recruitment maneuvers. Given that APRV is superior to CMV for the most severely injured lungs (ie, rescue mode) and that the MBP of APRV is theoretically ideal for minimizing ventilator injury cost function, we chose to study the effi cacy of this mechanical breath at reducing ARDS incidence. We hypothesized that the mechanism by which APRV protected the lung 24, [30] [31] [32] [33] [34] 44, 45 was reduced alveolar microstrain ( m -strain). We found that appropriately set APRV with an extended duration at plateau pressure (duration at high pressure [THigh] ) and a very brief duration at pressure release (duration at low pressure [TLow] ) is essential to minimizing m -strain in the alveoli and the alveolar ducts ( Figs 3 , 4 ) . 30, 44 m -Strain is defi ned as the change in size and shape of the alveoli and alveolar ducts in response to a given stress. In this case the stress applied is airway pressure. Both THigh and TLow can be adjusted dynamically and specifi cally to target an individual's pathophysiology via closed-loop feedback and together achieve lung protection via two mechanisms: (1) An extended THigh progressively recruits and stabilizes alveoli, which results in homogenous ventilation and elimination of stress Figure 30 ) concentrations, and (2) a very brief TLow does not allow enough time for alveolar collapse during exhalation, which minimizes alveolar m -strain.
-A, In vivo photomicrographs at inspiration and end expiration of subpleural alveoli (far left ) following surfactant deactivation with Tween. To assess the m -strain, individual alveoli were color-coded in yellow with nonalveolar tissue in red and the alveolar area calculated using computer image analysis at inspiration and expiration. Two settings for TLow using APRV and two PEEP levels with a V t of 6 mL/kg were studied with CMV. In the APRV group with improperly set TLow at 10% (ie, 90% of the lung volume was exhaled), there was large m -strain on the alveoli as they recruited and collapsed with each breath. Th ere was also signifi cant m -strain with CMV PEEP5 with less recruitment during inspiration. CMV PEEP16 reduced the m -strain but failed to recruit all alveolar whereas APRV with properly set TLow at 75% (25% of the lung volume was exhaled) both recruited and stabilized (ie, minimal m -strain) alveoli (original magnifi cation 3 10). B, Percentage of alveolar air space occupancy as determined by computer image analysis at inspiration and expiration. Alveolar air space occupancy is expressed as a percentage (%) of the photomicrograph containing infl ated alveoli (yellow) at inspiration (light gray) and expiration (dark gray). Th e larger the diff erence in airspace occupancy between inspiration and expiration, the larger the alveolar m -strain. Although the V t delivered to the lung with APRV 75% is approximately 12 mL/kg, 28,30 the alveolar V t (ie, the volume change of the individual alveoli with each breath) is very small as measured by the small measured m -strain. Th us, it is not the size of the V t being delivered to the lung but the size of the change in individual alveolar V t that is critical in preventing ventilator
We have shown signifi cant reductions in ARDS development with the preemptive application of APRV in a rat model of VILI 34 and in a rat hemorrhagic shock ARDS model. 32 In addition, we have demonstrated nearcomplete lung protection in a high-fi delity clinically applicable porcine ARDS model, 31, 33 which was associated with high PTI ( Fig 5B ) . Th ese studies thus confi rm, perhaps somewhat counterintuitively, that increasing PTI is actually protective, at least in the context of APRV, and reduces both alveolar and alveolar duct m -strain ( Figs 3, 4 ) . 30, 44 Th e result is reduced development of ARDS as measured by the Pa o 2 /F io 2 ratio ( Fig 5A ) and gross pathology ( Fig 6 ) . 31 APRV has also been shown to be eff ective at reducing ARDS incidence in patients in the ICU. We conducted a systematic review in high-risk trauma patients and demonstrated that preemptive MV with APRV blocks the progression of ALI ( Fig 7 ) . 24 Th is analysis compared APRV applied preemptively with 15 studies using standard-of-care ventilation applied only aft er acute lung injury has developed. Th e patients in the APRV group had a greater mean Injury Severity Score and a lung injury prediction score of . 8 (indicating a . 30% risk Figure 5 -A 24 ) of developing ARDS), but a very low incidence of ARDS (1.3%) and in-hospital mortality (3.6%) ( Fig 7 ) . Th us, preemptive APRV can reduce ARDS incidence in highrisk patients similar to, or even better than, preemptive LV t ventilation with PEEP and RMs. 20, 25, 26, 29, 39, 40, 46 
Mechanisms of APRV Protection
Th ere are three possible mechanisms by which the extended PTI produced by APRV reduces ARDS incidence: (1) preserving the integrity of the blood-gas barrier and thereby reducing pulmonary edema formation ( Fig 2 , increased permeability) , 47 thus blocking the sequence of events leading to surfactant deactivation, alveolar collapse, and subsequent alveolar instability ( Fig 2 , RACE) ; (2) minimizing alveolar collapse ( Fig 3 , RACE) with the very brief expiration that occurs during TLow, which limits the time for alveolar derecruitment to occur before the lung is reinfl ated ( Figs 3, 4 ) 30, 44 ; and (3) maximally recruiting the lung with the extended inspiratory duration THigh, which maintains distal airspace patency and creates a homogeneously ventilated lung so as to minimize stress concentrations in the parenchyma ( Fig 4 ) . 30 Th ese factors have all been linked to lung protection. 47 For example, Protti et al 47 have shown that high static strain near total lung capacity causes minimal lung injury, whereas dynamic strain at the same lung volume results in severe lung damage with pulmonary edema. 47 Minimizing dynamic strain has also been shown to preserve surfactant function, which would further reduce edema and stabilize alveoli ( Fig 2 , surfactant deactivation) . 48 Th ese studies suggest that the optimally protective breath involves the appropriate combination of multiple parameters, with the durations that these components are applied to the lung during each breath playing a key role in lung protection. 30, 33, 44 In a recent study, Amato et al 49 reveal that the protective mechanical breath is complex and not just a function of LV t . 49 In a retrospective meta-analysis of ARDSnet data, the authors demonstrated that lower driving pressure (ie, Vt/respiratory compliance) was strongly associated with increased survival. We also found evidence that LV t is not the exclusive means of protecting the lung. Our preemptive application of APRV in a clinically applicable porcine sepsis plus ischemia/reperfusion ARDS model was highly lung protective, despite a V t of 12 mL/kg, while a control group using a LV t strategy (ie, 6 mL/kg) resulted in less protection. 31 Although driving pressure per se was not measured in this study, all published data suggest that the components of driving pressures in APRV would be in the normal range, since the respiratory compliance remained near baseline values throughout the entire experiment. Th e APRV groups in these studies demonstrate preservation of normal preinjury lung compliance, while accommodating 12 mL/kg V t throughout the 48-h experiment. 31, 33 Th ere is reason to expect that future studies will identify other parameters of the mechanical breath with a substantial protective role.
Summary and Conclusions
Although we believe that APRV is highly eff ective in treating established ARDS or as a "rescue mode" in patients with such serious lung disease that standard MV is ineff ective, the exciting novel concept is the ability to signifi cantly reduce ARDS incidence in patients at high risk. No controlled randomized phase 3 trials have been conducted using any preemptive ventilation strategy, however, this may provide future direction. In small clinical studies it has been shown that properly adjusted CMV can reduce the incidence of ARDS in both patients in the ICU 20, 25, 26, 39, 40, 46 and in patients undergoing major surgery. 26, 28, 29 However the ideal combination of LV t , PEEP, and RMs has yet to be determined. Our group has shown that preemptive APRV may be superior to CMV at reducing the incidence of ARDS in both animal [31] [32] [33] [34] and human 24 studies. Ventilatory mode acronyms such as CMV, LV t , or APRV do not express all the features of a mechanical breath that determine its injurious or protective impact, without also defi ning temporal details of the mechanical breath which are critical to clinical outcome. Th e essential protective mechanism of APRV appears to be related to never letting the lung collapse, which eliminates mechanical damage to the pulmonary tissue caused by stress concentrations arising from alveolar heterogeneity and by dynamic alveolar m -strain with alveolar collapse and reopening. Th ese studies suggest that the ventilator can be used preemptively as a therapeutic tool to prevent ALI progression, thereby signifi cantly reducing ARDS incidence. Th is echoes the comments of Villar and Slutsky 50 that "ARDS is no longer a syndrome that must be treated, but is a syndrome that should be prevented. "
